Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 May;61(5):e182-e184.
doi: 10.1111/ijd.15742. Epub 2021 Jul 16.

Certolizumab pegol and its role in pregnancy-age hidradenitis suppurativa

Federica Repetto  1 , Lorenza Burzi  1 , Alice Ramondetta  1 , Giulia Rozzo  1 , Matteo Licciardello  1 , Simone Ribero  1 , Pietro Quaglino  1 , Paolo Dapavo  1
Affiliations
Comment

Certolizumab pegol and its role in pregnancy-age hidradenitis suppurativa

Federica Repetto et al. Int J Dermatol. 2022 May.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Wohlmuth-Wieser I, Alhusayen R. Treatment of hidradenitis suppurativa with Certolizumab pegol during pregnancy. Int J Dermatol 2021; 60: e140-e141.
    1. Perng P, Zampella JG, Okoye GA. Management of hidradenitis suppurativa in pregnancy. J Am Acad Dermatol 2017; 76: 979-989.
    1. Lyons AB, Peacock A, McKenzie SA, et al. Evaluation of hidradenitis suppurativa disease course during pregnancy and postpartum. JAMA Dermatol. 2020; 156: 681-685.
    1. Clowse MEB, Scheuerle AE, Chambers C, et al. Pregnancy outcomes after exposure to certolizumab pegol: updated results from a pharmacovigilance safety database. Arthritis Rheumatol 2018; 70: 1399-1407.
    1. Esme P, Akoglu G, Caliskan E. Rapid response to certolizumab pegol in hidradenitis suppurativa: a case report. Skin Appendage Disord. 2021; 7: 58-61.

Substances

LinkOut - more resources